Shifts in policy, innovation and advocacy ushering in new era for women’s health: a Perspective

Women’s health stands at a tipping point, poised between an underfunded niche and the next great frontier for drug development. A trillion-dollar market awaits those who move beyond opportunistic dabbling to building robust, data-driven women’s health platforms.

For decades, women were underrepresented in both basic research and clinical trials, leaving critical gaps in our understanding of female-specific diseases and sex-based differences in disease presentation, diagnosis, and outcomes...